OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis
Bryan C. Tan, Xin‐Hui Pan, Han Shi Jocelyn Chew, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 8, pp. 677-685
Closed Access | Times Cited: 38

Showing 26-50 of 38 citing articles:

Pharmacological management of testosterone deficiency in men current advances and future directions
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, et al.
Expert Review of Clinical Pharmacology (2024), pp. 1-17
Closed Access | Times Cited: 2

Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management
Ibrahim S. Alhomoud, Azita H. Talasaz, Preethi Chandrasekaran, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 9, pp. 738-752
Closed Access | Times Cited: 2

Charting New Territories in Obesity Management- Traditional Techniques to Tirzepatide
Areeba Fareed, Laura Ghanem, Rayyan Vaid, et al.
Endocrine Practice (2024)
Closed Access | Times Cited: 2

Pharmacotherapeutic strategies for the management of erectile dysfunction in patients with diabetes and pre-diabetes
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 16, pp. 2213-2223
Closed Access | Times Cited: 1

Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors
Vickram Vijay Anand, Jaycie Koh, Tian-Seng Teo, et al.
Clinical Research in Cardiology (2024)
Closed Access | Times Cited: 1

Data mining study on adverse events of tirzepatide based on FAERS database
Yan Huo, Minghua Ma, Xiaolan Liao
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access | Times Cited: 1

Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond
Aayushi Sood, Purnoor Kaur, Omar Syed, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 235-246
Closed Access

Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysis
xuyang gong, panpan cheng, yahui han, et al.
Research Square (Research Square) (2024)
Open Access

Prevalence and impact of a protein-truncating POMC variant on obesity in the Estonian Biobank
Erik Abner, Kanwal Batool, Nele Taba, et al.
Research Square (Research Square) (2024)
Open Access

Tirzepatide: la nuova sfida farmacologica al diabete e all’obesità
Emmanuele Capobianco, Uberto Pagotto, Silvia Garelli
L Endocrinologo (2024)
Closed Access

Obesity research: Moving from bench to bedside to population
Ann Marie Schmidt
PLoS Biology (2023) Vol. 21, Iss. 12, pp. e3002448-e3002448
Open Access | Times Cited: 1

Impact of Nutrient-Stimulated Hormone (NUSH) Dynamics on Body Weight
Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luísa Correia Matos de Oliveira, et al.
Research Square (Research Square) (2024)
Open Access

Previous Page - Page 2

Scroll to top